IL146474A0 - Benzothiazinone and benzoxazinone compounds - Google Patents

Benzothiazinone and benzoxazinone compounds

Info

Publication number: IL146474A0
Authority: IL; Israel
Prior art keywords: benzothiazinone; benzoxazinone compounds; benzoxazinone; compounds
Prior art date: 1999-06-03

Application number

IL14647400A

Other languages

English (en)

Original Assignee

Knoll Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-03

Filing date

2000-06-02

Publication date

2002-07-25

2000-06-02 Application filed by Knoll Gmbh filed Critical Knoll Gmbh

2002-07-25 Publication of IL146474A0 publication Critical patent/IL146474A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Neurology (AREA)
Obesity (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Transplantation (AREA)
Reproductive Health (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

IL14647400A 1999-06-03 2000-06-02 Benzothiazinone and benzoxazinone compounds IL146474A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13741099P	1999-06-03	1999-06-03
PCT/US2000/015324 WO2000075139A2 (en)	1999-06-03	2000-06-02	Benzothiazinone and benzoxazinone compounds

Publications (1)

Publication Number	Publication Date
IL146474A0 true IL146474A0 (en)	2002-07-25

Family

ID=22477310

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14647400A IL146474A0 (en)	1999-06-03	2000-06-02	Benzothiazinone and benzoxazinone compounds

Country Status (18)

Country	Link
US (1)	US7049312B1 (xx)
EP (1)	EP1181282A2 (xx)
JP (1)	JP2003501429A (xx)
KR (1)	KR20020062808A (xx)
CN (1)	CN1636005A (xx)
AR (1)	AR031830A1 (xx)
AU (1)	AU5179000A (xx)
BG (1)	BG106238A (xx)
BR (1)	BR0011063A (xx)
CA (1)	CA2375734A1 (xx)
CZ (1)	CZ20014244A3 (xx)
HK (1)	HK1046402A1 (xx)
IL (1)	IL146474A0 (xx)
MX (1)	MXPA01012442A (xx)
NO (1)	NO20015899L (xx)
PL (1)	PL352680A1 (xx)
WO (1)	WO2000075139A2 (xx)
ZA (1)	ZA200109610B (xx)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002085868A1 (en) *	2001-04-23	2002-10-31	Astrazeneca Ab	Benzoxazinone derivatives for use in the treatment of angiogenesis
CA2454080A1 (en)	2001-08-13	2003-02-27	Robert Edward Detlefsen	Ultraviolet light absorbers
RS95404A (sr) *	2002-05-03	2006-10-27	Schering Aktiengesellschaft	Tiazolidinoni i njihova primena kao inhibitora polo like kinaze
AR045037A1 (es)	2003-07-10	2005-10-12	Aventis Pharma Sa	Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
PT1696920E (pt)	2003-12-19	2015-01-14	Plexxikon Inc	Compostos e métodos para o desenvolvimento de moduladores de ret
US7498342B2 (en)	2004-06-17	2009-03-03	Plexxikon, Inc.	Compounds modulating c-kit activity
EP1831225A2 (en) *	2004-11-19	2007-09-12	The Regents of the University of California	Anti-inflammatory pyrazolopyrimidines
KR101325424B1 (ko) *	2005-01-28	2013-11-04	노파르티스 아게	Ｔｉｅ-2 키나제 활성의 조절에 반응하는 질환의 치료를위한 피리미딜아미노벤즈아미드의 용도
US10296720B2 (en)	2005-11-30	2019-05-21	Gearbox Llc	Computational systems and methods related to nutraceuticals
US8000981B2 (en)	2005-11-30	2011-08-16	The Invention Science Fund I, Llc	Methods and systems related to receiving nutraceutical associated information
US7974856B2 (en)	2005-11-30	2011-07-05	The Invention Science Fund I, Llc	Computational systems and methods related to nutraceuticals
US8297028B2 (en)	2006-06-14	2012-10-30	The Invention Science Fund I, Llc	Individualized pharmaceutical selection and packaging
US20080210748A1 (en) *	2005-11-30	2008-09-04	Searete Llc, A Limited Liability Corporation Of The State Of Delaware,	Systems and methods for receiving pathogen related information and responding
US8340944B2 (en)	2005-11-30	2012-12-25	The Invention Science Fund I, Llc	Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US7927787B2 (en)	2006-06-28	2011-04-19	The Invention Science Fund I, Llc	Methods and systems for analysis of nutraceutical associated components
US7827042B2 (en)	2005-11-30	2010-11-02	The Invention Science Fund I, Inc	Methods and systems related to transmission of nutraceutical associated information
EP2004654B1 (en)	2006-04-04	2013-05-22	The Regents of the University of California	Pyrazolopyrimidine derivatives for use as kinase antagonists
RS20080525A (sr)	2006-05-09	2009-09-08	Pfizer Products Inc.,	Derivati cikloalkilamino kiseline i njihove farmaceutske kompozicije
JP2008231088A (ja) *	2006-10-30	2008-10-02	Santen Pharmaceut Co Ltd	１，４−ベンゾオキサジン−３−オン骨格を有する新規化合物
WO2008053863A1 (en) *	2006-10-30	2008-05-08	Santen Pharmaceutical Co., Ltd.	Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton
WO2008063888A2 (en)	2006-11-22	2008-05-29	Plexxikon, Inc.	Compounds modulating c-fms and/or c-kit activity and uses therefor
FR2913019A1 (fr) *	2007-02-23	2008-08-29	Cerep Sa	Composes heterocycliques comme agents anti-neoplasiques ou inhibiteurs de proliferation cellulaire
SG183036A1 (en)	2007-07-17	2012-08-30	Plexxikon Inc	Compounds and methods for kinase modulation, and indications therefor
WO2009046448A1 (en)	2007-10-04	2009-04-09	Intellikine, Inc.	Chemical entities and therapeutic uses thereof
US8193182B2 (en)	2008-01-04	2012-06-05	Intellikine, Inc.	Substituted isoquinolin-1(2H)-ones, and methods of use thereof
MX2010007419A (es)	2008-01-04	2010-11-12	Intellikine Inc	Ciertas entidades quimicas, composiciones y metodos.
JP5547099B2 (ja) *	2008-03-14	2014-07-09	インテリカイン，エルエルシー	キナーゼ阻害剤および使用方法
WO2009114874A2 (en)	2008-03-14	2009-09-17	Intellikine, Inc.	Benzothiazole kinase inhibitors and methods of use
MX2010013191A (es) *	2008-06-24	2010-12-17	Hoffmann La Roche	Nuevas piridin-3-onas y piridazin-3-onas sustituidas.
US20110224223A1 (en)	2008-07-08	2011-09-15	The Regents Of The University Of California, A California Corporation	MTOR Modulators and Uses Thereof
US9096611B2 (en) *	2008-07-08	2015-08-04	Intellikine Llc	Kinase inhibitors and methods of use
CA2734305A1 (en) *	2008-08-15	2010-02-18	Board Of Regents, The University Of Texas System	1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions
JP5731978B2 (ja)	2008-09-26	2015-06-10	インテリカイン，エルエルシー	複素環キナーゼ阻害剤
AU2009305669A1 (en)	2008-10-16	2010-04-22	The Regents Of The University Of California	Fused ring heteroaryl kinase inhibitors
US8476431B2 (en)	2008-11-03	2013-07-02	Itellikine LLC	Benzoxazole kinase inhibitors and methods of use
CN106336400A (zh)	2008-12-08	2017-01-18	萌蒂制药国际有限公司	酪氨酸激酶蛋白受体拮抗剂
AU2010232670B2 (en)	2009-04-03	2015-07-09	F. Hoffmann-La Roche Ag	Propane- I-sulfonic acid {3- [5- (4 -chloro-phenyl) -1H-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof
CA2760791C (en)	2009-05-07	2017-06-20	Intellikine, Inc.	Heterocyclic compounds and uses thereof
WO2011047384A2 (en)	2009-10-16	2011-04-21	The Regents Of The University Of California	Methods of inhibiting ire1
ES2633317T3 (es)	2009-11-06	2017-09-20	Plexxikon, Inc.	Compuestos y métodos para la modulación de quinasas, e indicaciones para ello
CN103391936B (zh)	2010-04-30	2016-04-27	国立大学法人东京大学	抗癌剂
CN103002738A (zh)	2010-05-21	2013-03-27	英特利凯恩有限责任公司	用于激酶调节的化学化合物、组合物和方法
JP2013545749A (ja)	2010-11-10	2013-12-26	インフィニティーファーマシューティカルズ，インコーポレイテッド	複素環化合物及びその使用
US8809349B2 (en)	2011-01-10	2014-08-19	Infinity Pharmaceuticals, Inc.	Processes for preparing isoquinolinones and solid forms of isoquinolinones
CN103517710B (zh)	2011-02-07	2017-05-31	普莱希科公司	用于激酶调节的化合物
TWI558702B (zh)	2011-02-21	2016-11-21	普雷辛肯公司	醫藥活性物質的固態形式
CN103491962B (zh)	2011-02-23	2016-10-12	因特利凯有限责任公司	激酶抑制剂的组合及其用途
JP2014522396A (ja)	2011-05-27	2014-09-04	テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション	置換２−ベンジリデン−２Ｈ−ベンゾ［ｂ］［１，４］チアジン−３（４Ｈ）−オン、その誘導体及びその治療上の使用
US8969363B2 (en)	2011-07-19	2015-03-03	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
TWI565709B (zh)	2011-07-19	2017-01-11	英菲尼提製藥股份有限公司	雜環化合物及其用途
SG11201400310WA (en)	2011-08-29	2014-06-27	Infinity Pharmaceuticals Inc	Heterocyclic compounds and uses thereof
EP2751112B1 (en)	2011-09-02	2019-10-09	The Regents of The University of California	Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
US8940742B2 (en)	2012-04-10	2015-01-27	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
US9150570B2 (en)	2012-05-31	2015-10-06	Plexxikon Inc.	Synthesis of heterocyclic compounds
JPWO2013180265A1 (ja) *	2012-06-01	2016-01-21	武田薬品工業株式会社	複素環化合物
US8828998B2 (en)	2012-06-25	2014-09-09	Infinity Pharmaceuticals, Inc.	Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
WO2014011754A1 (en) *	2012-07-10	2014-01-16	Amir Tamiz	Novel 1, 4-benzoxazinone compounds
CA2886240A1 (en)	2012-09-26	2014-04-03	The Regents Of The University Of California	Modulation of ire1
WO2014060395A1 (en) *	2012-10-16	2014-04-24	F. Hoffmann-La Roche Ag	Serine/threonine kinase inhibitors
MX386085B (es)	2012-11-01	2025-03-18	Infinity Pharmaceuticals Inc	Tratamiento de canceres utilizando moduladores de las isoformas de pi3 cinasa
US9481667B2 (en)	2013-03-15	2016-11-01	Infinity Pharmaceuticals, Inc.	Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
US8999992B2 (en)	2013-03-15	2015-04-07	Vm Pharma Llc	Crystalline forms of tryosine kinase inhibitors and their salts
CN105189497B (zh) *	2013-03-19	2019-05-03	默沙东公司	作为janus激酶抑制剂的n-(2-氰基杂环基)吡唑并吡啶酮
CN105793255B (zh)	2013-10-04	2018-11-16	无限药品股份有限公司	杂环化合物及其用途
WO2015051241A1 (en)	2013-10-04	2015-04-09	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
CN103755659B (zh) *	2014-02-25	2015-07-15	山东大学	6-肉桂酰基-2H-苯并[b][1,4]噁嗪-3(4H)-酮类化合物及其应用
MX382033B (es)	2014-03-19	2025-03-13	Infinity Pharmaceuticals Inc	Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
US20150320755A1 (en)	2014-04-16	2015-11-12	Infinity Pharmaceuticals, Inc.	Combination therapies
WO2016043975A1 (en)	2014-09-17	2016-03-24	Vm Pharma Llc	Crystalline forms of tyrosine kinase inhibitors and their salts
WO2016054491A1 (en)	2014-10-03	2016-04-07	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
US10160761B2 (en)	2015-09-14	2018-12-25	Infinity Pharmaceuticals, Inc.	Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
US10759806B2 (en)	2016-03-17	2020-09-01	Infinity Pharmaceuticals, Inc.	Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
US10919914B2 (en)	2016-06-08	2021-02-16	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
RU2754507C2 (ru)	2016-06-24	2021-09-02	Инфинити Фармасьютикалз, Инк.	Комбинированная терапия
CN111727189B (zh)	2017-12-01	2023-10-03	伊利诺伊大学董事会	基于吡啶酮的表观遗传修饰剂及其用途
EP4214192A4 (en) *	2020-09-20	2024-09-25	Tactogen Inc.	BENEFICIAL TRYPTAMINE COMPOSITIONS FOR IMPROVING MENTAL DISORDERS
CN114601825B (zh) *	2022-02-18	2023-08-04	复旦大学附属中山医院	一种肠道菌群代谢物吲哚-3-甲醛在防治动脉粥样硬化中的应用
US11780838B1 (en)	2023-03-23	2023-10-10	King Faisal University	Pyrrolo[3,2-b]quinoline compounds as antibacterial agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3635956A (en)	1968-03-01	1972-01-18	Squibb & Sons Inc	Benzothiazines related compounds derivatives and salts thereof
DE2051474A1 (de)	1969-10-28	1971-05-06	ER Squibb & Sons Ine , New York, N Y (V St A )	Heterocyclische Verbindungen, ihre Salze, Verfahren zu ihrer Herstellung und ihre Verwendung
US3812114A (en)	1971-09-29	1974-05-21	Squibb & Sons Inc	Benzothiazines
US3865818A (en)	1973-10-24	1975-02-11	Squibb & Sons Inc	Substituted benzoxazines
US3923709A (en)	1974-08-30	1975-12-02	Monsanto Co	3,4-Dihydro-3-oxo-2H-1,4-benzothiazines and benzoxazines
JPS6072875A (ja) *	1983-09-28	1985-04-24	Hamari Yakuhin Kogyo Kk	１，５−ベンゾチアゼピン誘導体およびその製造法
US4490292A (en)	1983-10-07	1984-12-25	Hamari Chemicals, Ltd.	1,5-Benzothiazepine derivatives and production thereof
JPS61229874A (ja) *	1985-04-03	1986-10-14	Toubishi Yakuhin Kogyo Kk	ベンゾチアジン誘導体の製造方法
CA2122370A1 (en)	1992-08-31	1994-03-17	Yoichi Kawashima	3-oxo-1,4-benzothiazine derivatives
WO1995013269A1 (en)	1993-11-12	1995-05-18	Santen Pharmaceutical Co., Ltd.	1,4-benzothiazine derivative

2000
- 2000-06-02 HK HK02106280.4A patent/HK1046402A1/zh unknown
- 2000-06-02 CZ CZ20014244A patent/CZ20014244A3/cs unknown
- 2000-06-02 BR BR0011063-9A patent/BR0011063A/pt not_active Application Discontinuation
- 2000-06-02 JP JP2001502421A patent/JP2003501429A/ja not_active Withdrawn
- 2000-06-02 WO PCT/US2000/015324 patent/WO2000075139A2/en not_active Ceased
- 2000-06-02 US US09/585,925 patent/US7049312B1/en not_active Expired - Lifetime
- 2000-06-02 AU AU51790/00A patent/AU5179000A/en not_active Abandoned
- 2000-06-02 CA CA002375734A patent/CA2375734A1/en not_active Abandoned
- 2000-06-02 CN CNA008111138A patent/CN1636005A/zh active Pending
- 2000-06-02 EP EP00936476A patent/EP1181282A2/en not_active Withdrawn
- 2000-06-02 KR KR1020017015588A patent/KR20020062808A/ko not_active Withdrawn
- 2000-06-02 IL IL14647400A patent/IL146474A0/xx unknown
- 2000-06-02 MX MXPA01012442A patent/MXPA01012442A/es unknown
- 2000-06-02 PL PL00352680A patent/PL352680A1/xx not_active Application Discontinuation
- 2000-06-05 AR ARP000102783A patent/AR031830A1/es unknown
2001
- 2001-11-21 ZA ZA200109610A patent/ZA200109610B/xx unknown
- 2001-12-03 NO NO20015899A patent/NO20015899L/no not_active Application Discontinuation
- 2001-12-19 BG BG106238A patent/BG106238A/xx unknown

Also Published As

Publication number	Publication date
US7049312B1 (en)	2006-05-23
CN1636005A (zh)	2005-07-06
ZA200109610B (en)	2003-04-30
CZ20014244A3 (cs)	2002-07-17
EP1181282A2 (en)	2002-02-27
BR0011063A (pt)	2002-04-16
KR20020062808A (ko)	2002-07-31
WO2000075139A3 (en)	2001-03-29
PL352680A1 (en)	2003-09-08
CA2375734A1 (en)	2000-12-14
JP2003501429A (ja)	2003-01-14
HK1046402A1 (zh)	2003-01-10
NO20015899L (no)	2002-01-30
BG106238A (en)	2002-08-30
AR031830A1 (es)	2003-10-08
NO20015899D0 (no)	2001-12-03
MXPA01012442A (es)	2004-09-10
AU5179000A (en)	2000-12-28
WO2000075139A2 (en)	2000-12-14

Publication	Publication Date	Title
IL146474A0 (en)	2002-07-25	Benzothiazinone and benzoxazinone compounds
GB0015176D0 (en)	2000-08-09	Early entry
GB0016917D0 (en)	2000-08-30	Early entry
GB0126363D0 (en)	2002-01-02	Early entry
DE60044099D1 (en)	2010-05-12	Trifluormethylpyrrolcarbonsäureamide und trifluormethylpyrrolthiocarbonsäureamide als fungizide
GB2357761B (en)	2001-09-05	Compounds
EP1078341A4 (en)	2010-01-06	PROXIMITY SENSOR
IL150059A0 (en)	2002-12-01	Novel heterocycles
DE60002821D1 (en)	2003-06-26	Reversibel photokuppelnde nukleinsäure und phosphoramidit
DE60013243D1 (en)	2004-09-30	Immunochromatographisches teststück und chromatographische analysenmethode
IL149021A0 (en)	2002-11-10	Leptin assay
GB0205052D0 (en)	2002-04-17	Early entry
GB0025045D0 (en)	2000-11-29	Early Entry
GB9902399D0 (en)	1999-03-24	Compounds
DE50010914D1 (en)	2005-09-15	Emissionsarme und hydrolysestabile polyurethan-schaumstoffe
GB0003496D0 (en)	2000-04-05	Improved worktable
GB0023554D0 (en)	2000-11-08	Early entry
GB9925829D0 (en)	1999-12-29	Disposal means
GB9909583D0 (en)	1999-06-23	Incinerator
GB9901101D0 (en)	1999-03-10	Proximity sensor
GB9810175D0 (en)	1998-07-08	Phosphate-medicated cyclization
GB9825689D0 (en)	1999-01-20	Degradable baitledger
AU142478S (en)	2000-12-12	Ring
AU142337S (en)	2000-11-21	Ring
GB0113222D0 (en)	2001-07-25	Waste fitting